Browse > Article

Protective Effect of Fibroin BF-7 on Neuronal Cell Death in Alzheimer Model using Amyloid $\beta$ Peptide  

Lee, Do-Yeon (Department of Anatomy, College of Medicine, Chung-Ang University)
Yu, Ji-Young (Department of Anatomy, College of Medicine, Chung-Ang University)
Kim, Jang-Il (Department of Anatomy, College of Medicine, Chung-Ang University)
Kim, Do-Hee (Department of Anatomy, College of Medicine, Chung-Ang University)
Han, In-Sook (Department of Anatomy, College of Medicine, Chung-Ang University)
Lee, Won-Bok (Department of Anatomy, College of Medicine, Chung-Ang University)
Publication Information
Anatomy and Cell Biology / v.40, no.1, 2007 , pp. 57-67 More about this Journal
Abstract
Factors such as senescence, stress and neurodegenerative diseases, including Alzheimer’s disease, contribute to the impairment of organs, especially the brain. They also negatively affect normal brain functions such as memory and cognition. In this study, the neuroprotective role of the natural product BF-7 was examined against Aβ- induced neurotoxicity in SK-N-SH human neuronal cells. BF-7 significantly attenuated Aβ-induced apoptosis as measured by intracellular calcium levels, accumulation of reactive oxygen species, mitochondrial dysfunction, and caspase activity. These results strongly indicate that BF-7 plays an effective and positive role in the improvement of brain functions, including learning and memory, in our model system for Alzheimer’s disease. Thus, BF-7 might be useful for developing strategies to protect the nervous system and improve brain function.
Keywords
Alzheimer's disease; Amyloid beta (A$\beta$); BF-7; Calcium; Mitochondria; Oxidative stress;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Chu CT, Levinthal DJ, kulich SM, Chalovich EM, CeFranco DB: Oxidative neuronal injury. Eur J Biochem 271: 2060-2066, 2004   DOI   ScienceOn
2 Emerit J, Edeas M, Bricaire F: Neurodegenerative disease and oxidative stress. Biomedicine and Pharmacotherapy 58: 39-46, 2003
3 Forloni G, Tagliavini F, Bugiani O, Salmona M: Amyloid in Alzheimer's disease and prion-related encephalopathies: Studies with synthetic peptides. Prog Neurobiol 49: 287- 315, 1996   DOI   PUBMED
4 Geldmacher DS, Whitehouse PJ: Evaluation of dementia. N Engl J Med 335: 330-336, 1996   DOI   ScienceOn
5 Giacobini E: Cholinesterase inhibitors stabilize Alzheimer's disease. Ann NY Acad Sci 920: 321-327, 2000   DOI
6 Mayeux R, Sano M: Treatment of Alzheimer's disease. N Engl J Med 341: 1670-1679, 1999   DOI   ScienceOn
7 Selkoe DJ: Amyloid beta-protein and the genetics of Alzheimer's disease. J Biol Chem 271: 18295-18298, 1996   DOI   PUBMED
8 Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K: Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375: 754-760, 1995   DOI   ScienceOn
9 Soto C, Barnes MC, Alzarez J, Inestrosa NC: Structural determinants of the Alzheimer's amyloid $\beta$-peptide. J Neurochem 63: 1191-1198, 1994   DOI   PUBMED   ScienceOn
10 Gonzalez-Polo RA, Soler G, Alonso JC, Rodriguez-Martin A, Fuentes JM: MPP (+) causes inhibition of cellular energy supply in cerebellar granule cells. Neurotoxicology 24: 219-225, 2003   DOI   ScienceOn
11 Campion D, Brice A, Dumanchin C, Puel M, Baulac M, De La Sayette V, Hannequin D, Duyckaerts C, Michon A, Martin C, Moreau V, Penet C, Martinez M, Clerget-Darpoux F, Agid Y, Frebourg T: A novel presenilin 1 mutation resulting in familial Alzheimer's disease with an onset age of 29 years. Neuroreport 8: 1582-1584, 1996
12 Fayuk D, Yakel JL: Regulation of nicotinic acetylcholine receptor channel function by acetylcholinesterase inhibitors in rat hippocampal CA1 interneurons. Mol Pharmacol 66: 658- 666, 2004   DOI   ScienceOn
13 Cleeter MW, Cooper JM: Schapira AH: Nitric oxide enhances MPP (+) inhibition of complex I. FEBS Lett 24: 50-52, 2001
14 Shimoke K, Chiba H: Nerve growth factor prevents 1-methyl-4- penyl-1, 2, 3, 6-tetrahydropyridine-induced cell death via the Akt athway by suppressing caspase-3-like activity using PC12 cells: relevance to therapeutical application for Parkinson's disease. J Neurosci Res 63: 402-409, 2001   DOI   ScienceOn
15 Chae HS, Kang YK, Shin YK, Lee HJ, Yu JI, Lee KG, Yoo JH, Kim YS, Shon DS, Kim KY, Lee WB, Lee SH, Kim SS: The role of BF-7 on neuroprotection and enhancement of cognitive function. Korean J Physiol Pharmacol 8: 173- 179, 2004   과학기술학회마을
16 Liu Q, Zhao B: Nicotine attenuates beta-amyloid peptide-induced neurotoxicity, free radical and calcium accumulation in hippocampal neuronal cultures. Br J Pharmacol 141: 746- 754, 2004   DOI   ScienceOn
17 Mizuno Y, Ikebe S, Hattori N, Kondo T, Tanaka M, Ozawa T: Mitochondrial energy crisis in Parkinson's disease. Adv Neurol 60: 282-287, 1993   PUBMED
18 Andersen JK: Oxidative stress in neurodegeneration: Cause or consequence? Nature Neurosci 1: 518-523, 2004
19 Amenta F, Parnetti L, Gallai V, Wallin A: Treatment of cognitive dysfunction associated with Alzheimer's disease with cholinergic precursors: Ineffective treatments or inappropriate approaches? Mech Ageing Dev 122: 2025-2040, 2001   DOI   ScienceOn
20 Launer LJ, Andersen K, Dewey ME, Letenneur L, Ott A, Amaducci LA, Brayne C, Copeland JR, Dartigues JF, Kragh-Sorensen P, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A: Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology 1: 78-84, 1999
21 Antonsson B, Martinou JC: The Bcl-2 protein family. Exp Cell Res 10: 50-57, 2000
22 Mattson MP, Daun W, Pedersen WA, Culmsee C: Neurodegenerative disorders and ischemic brain disease. Apoptosis 6: 69-81, 2001   DOI   ScienceOn
23 Antonsson B, Conti F, Ciavatta A, Montessuit S, Lewis S, Martinou I, Bernasconi L, Bernard A, Mermod JJ, Mazzei G, Maundrell K, Gambale F, Sadoul R, Martinou JC: Inhibition of Bax channel-forming activity by Bcl-2. Science 18: 370-372, 1997